![Patricia van Dijck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patricia van Dijck is currently the Director-Market Access & Public Affairs at GSK Belux since 2018.
Prior to this, she worked as an Independent Director at Mithra Pharmaceuticals SA from 2021 to 2023, as a Medical Director at Lundbeck SA from 1998 to 2007, and as the Head-Market Access & Public Affairs at Novartis Belux.
She holds a doctorate degree from the Université Catholique de Louvain.
| Sociétés | Poste | Début |
|---|---|---|
GSK Belux | Public Communications Contact | 01/01/2018 |
| Sociétés | Poste | Fin |
|---|---|---|
| MITHRA PHARMACEUTICALS S.A. | Président | 01/06/2021 |
Novartis Belux | Public Communications Contact | - |
Lundbeck SA
 Lundbeck SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
Mithra Pharmaceuticals SA
 Mithra Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for woman health sector | Health Technology |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck SA
Lundbeck SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Novartis Belux | |
GSK Belux |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
